NEXTURNBIOSCIENCE Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 79.26 million compared to KRW 71.76 million a year ago. Net income was KRW 239.64 million compared to net loss of KRW 2,617.47 million a year ago. Basic earnings per share from continuing operations was KRW 16 compared to basic loss per share from continuing operations of KRW 470 a year ago. Diluted earnings per share from continuing operations was KRW 16 compared to diluted loss per share from continuing operations of KRW 470 a year ago. Basic earnings per share was KRW 26 compared to basic loss per share of KRW 387 a year ago. Diluted earnings per share was KRW 26 compared to diluted loss per share of KRW 387 a year ago.
For the nine months, sales was KRW 257.78 million compared to KRW 134.06 million a year ago. Net income was KRW 31,564.83 million compared to KRW 677.8 million a year ago. Basic earnings per share from continuing operations was KRW 3,559 compared to KRW 18 a year ago. Diluted earnings per share from continuing operations was KRW 3,327 compared to KRW 73 a year ago. Basic earnings per share was KRW 3,610 compared to KRW 104 a year ago. Diluted earnings per share was KRW 3,375 compared to KRW 132 a year ago.